Pediatric Cardiology • Parent Guide
Kawasaki Disease
The most common cause of acquired heart disease in children in developed countries — and one that is frequently missed in its early days.
📚 AHA Scientific Statement on Kawasaki Disease (2017) | Nelson’s Textbook of Pediatrics, 21st Ed. | Moss & Adams, 10th Ed.
👨⚕️ Pediatric Cardiology
KEY STATS
| #1 | Days 1–10 | 25% | <1% |
|---|---|---|---|
| Cause of acquired heart disease in children in developed countries | Window for treatment to prevent coronary complications | Of untreated children develop coronary artery aneurysms | Coronary aneurysm rate with early IVIG treatment |
🫀 What Is Kawasaki Disease?
Kawasaki disease (KD) is an acute inflammatory condition of blood vessels (vasculitis) that primarily affects children under 5 years of age. It was first described by Japanese physician Tomisaku Kawasaki in 1967.
The exact cause remains unknown, though current evidence points to an infectious trigger (possibly a common virus or bacteria) in a genetically predisposed child that provokes an abnormal immune response, causing widespread inflammation of small and medium-sized arteries throughout the body.
The arteries most critically affected are the coronary arteries — the blood vessels that supply the heart muscle. Inflammation of the coronary arteries can cause them to balloon outward, forming coronary artery aneurysms — the most serious and potentially lasting consequence of KD.
⚠️ Why Early Diagnosis Matters More Than Almost Anything
With treatment (high-dose aspirin + intravenous immunoglobulin / IVIG) given within the first 10 days of fever, the risk of coronary aneurysms drops from 25% to less than 1%. After day 10, treatment is less effective and some damage may already be established. This is why KD must be in every doctor’s mind when a young child has unexplained prolonged fever with the right constellation of features — and why parents knowing these features can save a child’s coronary arteries.
The Diagnostic Criteria — What to Watch For
Kawasaki disease is diagnosed clinically — there is no single blood test. The classical diagnosis requires fever for ≥5 days plus at least 4 of 5 features:
| Feature | What It Looks Like |
|---|---|
| Conjunctival injection | Red eyes — white of the eye is red/pink, but without discharge (not like conjunctivitis) |
| Rash | Polymorphous (various shapes) rash over trunk — not blistering |
| Mouth changes | Cracked, red lips; “strawberry tongue” (bright red with prominent taste buds); red throat |
| Hand and foot changes | Swollen hands and feet (oedema) in acute phase; peeling of skin from fingertips and toes in week 2–3 |
| Lymph node | Enlarged lymph node in neck, usually one side, ≥1.5 cm |
Fever + 4 of these 5 features = Classical Kawasaki disease. A cardiologist should be involved urgently.
💡 Incomplete Kawasaki Disease
Up to 20–30% of children — particularly infants under 6 months — do not meet the full classical criteria but still have KD and still develop coronary aneurysms. This is called incomplete (or atypical) Kawasaki disease. Infants under 6 months with prolonged unexplained fever, even without all 5 features, should be evaluated for KD. An echocardiogram is the critical test in these cases — coronary artery dilation is a diagnostic finding even without full clinical criteria.
The Phases of Kawasaki Disease
| Phase | Timing | What Happens |
|---|---|---|
| Acute | Days 1–10 | High fever, all 5 clinical features present; inflammation at peak; coronary arteries at risk |
| Subacute | Weeks 2–4 | Fever resolves; peeling of hands and feet; platelet count rises very high (thrombocytosis); aneurysm risk if untreated |
| Convalescent | 6–8 weeks | Clinical features resolve; coronary arteries begin to remodel; lab markers normalise |
| Chronic | Months to years | Most aneurysms regress; large aneurysms may persist; long-term cardiology monitoring |
🔧 Treatment
1. IVIG (Intravenous Immunoglobulin)
The cornerstone of treatment. A single high dose (2 g/kg infused over 10–12 hours) dramatically reduces the duration of fever and — critically — the risk of coronary aneurysm formation. Mechanism: not fully understood, but modulates the aberrant immune response. Must be given within the first 10 days of fever for maximum effect.
2. Aspirin
High-dose aspirin (30–50 mg/kg/day) during the acute phase for its anti-inflammatory effect. Once fever resolves, dose is reduced to low-dose (3–5 mg/kg/day) for its antiplatelet (blood-thinning) effect — maintained until coronary arteries confirmed normal at 6–8 weeks.
3. IVIG-Resistant KD (10–20% of Cases)
Some children do not respond to the first IVIG dose (fever persists or recurs within 36 hours). These children need a second IVIG dose, or additional treatment with infliximab (anti-TNF antibody), corticosteroids, or other immunomodulatory agents. They are at higher risk for coronary complications and need intensive monitoring.
4. Anticoagulation for Large Aneurysms
Children who develop large (giant) coronary aneurysms (internal diameter >8 mm) are at risk of thrombosis within the aneurysm — which can cause a heart attack. These children are anticoagulated with warfarin or low-molecular-weight heparin long-term, in addition to aspirin.
Coronary Artery Involvement — Grading
| Category | Definition | Management |
|---|---|---|
| No involvement | Normal coronary arteries on echo | Aspirin until 6–8 weeks; no long-term restrictions |
| Dilation only (z-score 2–2.5) | Mildly enlarged but not aneurysm | Low-dose aspirin 6–12 weeks; repeat echo |
| Small aneurysm (z-score 2.5–5) | Aneurysm <5 mm internal diameter | Low-dose aspirin; echo every 6–12 months |
| Medium aneurysm (z-score 5–10) | 5–8 mm diameter | Aspirin ± anticoagulation; regular echo; exercise restriction |
| Giant aneurysm (z-score >10) | >8 mm diameter | Long-term anticoagulation; activity restriction; coronary imaging; lifelong follow-up |
❓ Frequently Asked Questions
Q: My child had fever for 5 days and the doctor initially thought it was viral — how is Kawasaki disease missed?
Very easily, in the early days. The features of KD appear sequentially — not all at once. A child on day 2 of fever may have only red eyes and a rash — which looks like viral illness. It is only by day 4–6, when mouth changes and hand/foot swelling appear, that the pattern becomes clearer. This is why any child with unexplained fever lasting beyond 4–5 days should be reviewed again with KD specifically considered, rather than assuming viral illness will resolve.
Q: My child was diagnosed and treated with IVIG — does that mean the heart is definitely fine?
Not necessarily — it means the risk is dramatically reduced, but it doesn’t guarantee no coronary involvement. An echocardiogram should be performed at diagnosis, and then at 2 weeks and 6–8 weeks after onset to assess the coronary arteries. If the echocardiogram at 6–8 weeks is normal and aspirin has been maintained, the prognosis is excellent and no long-term restrictions are needed.
Q: My child developed a coronary aneurysm — will it go away?
Many small and medium aneurysms resolve (regress) within 1–2 years as the vessel wall remodels. Small aneurysms have an excellent prognosis. Large and giant aneurysms may not fully regress and require long-term anticoagulation, activity restrictions, and periodic coronary imaging. The cardiologist will track the aneurysm size over time and adjust management accordingly.
Q: My child’s Kawasaki disease was treated late (after day 10) — does that mean they will definitely have aneurysms?
Not definitely. IVIG given after day 10 is less effective but may still reduce inflammation and risk. The echo at 6–8 weeks will give the most important information — whether coronary arteries are involved and to what degree. Many children treated late still have normal coronary arteries. If aneurysms are present, their size determines the management plan.
Q: Can Kawasaki disease come back?
Recurrence is rare — occurring in approximately 1–3% of cases. A child who has had KD once should have it considered again if they develop another prolonged unexplained fever in later childhood, particularly if the previous episode was associated with coronary changes. Subsequent episodes tend to be milder but still require prompt treatment.
Q: Are there any long-term activity restrictions if the coronary arteries were normal?
No. Children with Kawasaki disease and confirmed normal coronary arteries at 6–8 weeks of illness can return to fully unrestricted physical activity — sport, swimming, PE, and competitive athletics. There is no long-term cardiac risk in this group. The only caveat: aspirin should not be given live vaccines (varicella, MMR) while on aspirin — coordinate with your paediatrician for catch-up vaccination once aspirin is stopped.
🎯 Key Takeaways
- Kawasaki disease is an inflammatory vasculitis that primarily affects children under 5 and is the leading cause of acquired heart disease in children in developed countries.
- Diagnosis requires fever ≥5 days plus 4 of 5 features: red eyes, rash, mouth changes, hand/foot changes, lymph node enlargement.
- Incomplete KD (fewer features, especially in infants <6 months) is common — echocardiogram is key.
- Treatment within 10 days with IVIG reduces coronary aneurysm risk from 25% to <1%.
- Echocardiograms at diagnosis, 2 weeks, and 6–8 weeks confirm coronary artery status.
- Children with normal coronary arteries at 6–8 weeks have an excellent prognosis and no long-term restrictions.
- Giant aneurysms require long-term anticoagulation and lifelong cardiology follow-up.
📚 References & Sources
McCrindle BW et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017;135(17):e927–e999.
Kliegman RM et al. Nelson Textbook of Pediatrics, 21st Ed. Elsevier, 2020.
Allen HD et al. Moss & Adams’ Heart Disease in Infants, Children, and Adolescents, 10th Ed. Wolters Kluwer, 2022.
© PedHeartIndia | www.pedheartindia.com — Educational purposes only.
A note from Dr. Sunil: This article is general educational information and is not a substitute for personal medical advice. For any concern about your child’s heart, please see a qualified doctor in person.
